Insulin treatment and high-fat diet feeding reduces the expression of three Tcf genes in rodent pancreas

Journal of Endocrinology

Volumn 207, Issue 1, 2010, Pages 77-86

  Columbus, Joshua ^a,b   Chiang, YuTing ^a,b   Shao, Weijuan ^b   Zhang, Nina ^a   Wang, Dingyan ^b   Gaisano, Herbert Y ^a   Wang, Qinghua ^a,c   Irwin, David M ^a   Jin, Tianru ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; T CELL FACTOR PROTEIN; WNT PROTEIN; FAT INTAKE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HNF1A PROTEIN, MOUSE; MESSENGER RNA; PRIMER DNA; TCF7L1 PROTEIN, HUMAN; TCF7L1 PROTEIN, MOUSE; TCF7L2 PROTEIN, HUMAN; TCF7L2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR 7 LIKE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; FEEDING; GENE EXPRESSION; HYPERINSULINEMIA; LIPID DIET; MALE; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FAT INTAKE; FEMALE; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PREGNANCY; RAT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WISTAR RAT;

ANIMALS; BASE SEQUENCE; CELL LINE; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DNA PRIMERS; DOWN-REGULATION; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; IN VITRO TECHNIQUES; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, TRANSGENIC; PANCREAS; PREGNANCY; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; T CELL TRANSCRIPTION FACTOR 1; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR 7-LIKE 1 PROTEIN; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; WNT PROTEINS;

EID: 77957132311     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0044     Document Type: Article

References (45)

1. Ahlzen M, Johansson LE, Cervin C, Tornqvist H, Groop L & Ridderstrale M 2008 Expression of the transcription factor 7-like 2 gene (TCF7L2) in human adipocytes is down regulated by insulin. Biochemical and Biophysical Research Communications 370 49-52. (doi:10.1016/j.bbrc.2008.03.006)
2. Barker N, Huls G, Korinek V & Clevers H 1999 Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. American Journal of Pathology 154 29-35. (Pubitemid 29031608)
3. Brinkmeier ML, Potok MA, Davis SW & Camper SA 2007 TCF4 deficiency expands ventral diencephalon signaling and increases induction of pituitary progenitors. Developmental Biology 311 396-407. (doi:10.1016/j.ydbio.2007.08. 046)
4. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D et al. 2007 TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. Journal of Molecular Medicine 85 777-782. (doi:10.1007/s00109- 007-0203-4)
5. Dahlgren A, Zethelius B, Jensevik K, Syvanen AC & Berne C 2007 Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men. Diabetologia 50 1852-1857. (doi:10.1007/s00125-007-0746-5) (Pubitemid 47222863)
6. Drucker DJ, Jin T, Asa SL, Young TA & Brubaker PL 1994 Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Molecular Endocrinology 8 1646-1655. (doi:10. 1210/me.8.12.1646)
7. Duval A, Busson-Leconiat M, Berger R & Hamelin R 2000a Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3. Cytogenetics and Cell Genetics 88 264-265. (doi:10.1159/000015534)
8. Duval A, Rolland S, Tubacher E, Bui H, Thomas G & Hamelin R 2000b The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Research 60 3872-3879.
9. Elbein SC 2007 Evaluation of polymorphisms known to contribute to risk for diabetes in African and African - American populations. Current Opinion in Clinical Nutrition and Metabolic Care 10 415-419. (doi:10.1097/MCO. 0b013e3281e2c99a)
10. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM & Altshuler D 2006 TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. New England Journal of Medicine 355 241-250. (doi:10.1056/NEJMoa062418)
11. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A et al. 2006 Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics 38 320-323. (doi:10.1038/ng1732)
12. Gregorieff A, Grosschedl R & Clevers H 2004 Hindgut defects and transformation of the gastro-intestinal tract in Tcf4(-/-)/Tcf1(-/-) embryos. EMBO Journal 23 1825-1833. (doi:10.1038/sj.emboj.7600191) (Pubitemid 38649645)
13. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B & Kinzler KW 1998 Identification of c-MYC as a target of the APC pathway. Science 281 1509-1512. (doi:10.1126/science.281. 5382.1509)
14. Jin T 2008 The WNT signalling pathway and diabetes mellitus. Diabetologia 51 1771-1780. (doi:10.1007/s00125-008-1084-y)
15. Jin T & Drucker DJ 1996 Activation of proglucagon gene transcription through a novel promoter element by the caudal-related homeodomain protein cdx-2/3. Molecular and Cellular Biology 16 19-28.
16. Jin T & Liu L 2008 The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Molecular Endocrinology 22 2383-2392. (doi:10.1210/me. 2008-0135)
17. Jin T, George Fantus I & Sun J 2008 Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin. Cellular Signalling 20 1697-1704. (doi:10.1016/j.cellsig.2008.04.014)
18. Kinzler KW & Vogelstein B 1996 Lessons from hereditary colorectal cancer. Cell 87 159-170. (doi:10.1016/S0092-8674(00)81333-1)
19. Kirchhoff K, Machicao F, Haupt A, Schafer SA, Tschritter O, Staiger H, Stefan N, Haring HU & Fritsche A 2008 Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 51 597-601. (doi:10.1007/s00125-008-0926-y)
20. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ & Clevers H 1998 Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genetics 19 379-383. (doi:10.1038/1270)
21. Krutzfeldt J & Stoffel M 2010 Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice. Diabetologia 53 123-127. (doi:10.1007/s00125-009-1578-2)
22. Lee S, Lee CE, Elias CF & Elmquist JK 2009 Expression of the diabetes-associated gene TCF7L2 in adult mouse brain. Journal of Comparative Neurology 517 925-939. (doi:10.1002/cne.22199)
23. Liu Z & Habener JF 2008 Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. Journal of Biological Chemistry 283 8723-8735. (doi:10.1074/jbc.M706105200)
24. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjogren M, Ling C, Eriksson KF, Lethagen AL et al. 2007 Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. Journal of Clinical Investigation 117 2155-2163. (doi:10.1172/JCI30706)
25. Munoz J, Lok KH, Gower BA, Fernandez JR, Hunter GR, Lara-Castro C, De Luca M & Garvey WT 2006 Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women. Diabetes 55 3630-3634. (doi:10.2337/db06-0574)
26. Philippe J 1989 Glucagon gene transcription is negatively regulated by insulin in a hamster islet cell line. Journal of Clinical Investigation 84 672-677. (doi:10.1172/JCI114214)
27. Philippe J 1991 Insulin regulation of the glucagon gene is mediated by an insulin-responsive DNA element. PNAS 88 7224-7227. (doi:10.1073/pnas.88.16. 7224) (Pubitemid 21915122)
28. Prokunina-Olsson L, Kaplan LM, Schadt EE & Collins FS 2009a Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes. PLoS ONE 4 e7231. (doi:10.1371/journal.pone. 0007231)
29. Prokunina-Olsson L, Welch C, Hansson O, Adhikari N, Scott LJ, Usher N, Tong M, Sprau A, Swift A, Bonnycastle LL et al. 2009b Tissue-specific alternative splicing of TCF7L2. Human Molecular Genetics 18 3795-3804. (doi:10.1093/hmg/ddp321)
30. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL & MacDougald OA 2000 Inhibition of adipogenesis by Wnt signaling. Science 289 950-953. (doi:10.1126/science.289.5481.950)
31. Rulifson IC, Karnik SK, Heiser PW, ten Berge D, Chen H, Gu X, Taketo MM, Nusse R, Hebrok M & Kim SK 2007 Wnt signaling regulates pancreatic beta cell proliferation. PNAS 104 6247-6252. (doi:10.1073/pnas.0701509104)
32. Schafer SA, Tschritter O, Machicao F, Thamer C, Stefan N, Gallwitz B, Holst JJ, Dekker JM, t'Hart LM, Nijpels G et al. 2007 Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50 2443-2450. (doi:10.1007/s00125- 007-0753-6)
33. Schinner S, Ulgen F, Papewalis C, Schott M, Woelk A, Vidal-Puig A & Scherbaum WA 2008 Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules. Diabetologia 51 147-154. (doi:10.1007/s00125-007-0848-0)
34. Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU, Narisu N, Duren WL, Chines PS, Stringham HM, Erdos MR et al. 2006 Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 55 2649-2653. (doi:10.2337/db06-0341)
35. Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M et al. 2003 The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Clinical Cancer Research 9 2121-2132.
36. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J & Maedler K 2008 Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57 645-653. (doi:10.2337/db07- 0847)
37. Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH & Maedler K 2009 Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Human Molecular Genetics 18 2388-2399. (doi:10.1093/hmg/ddp178)
38. Sirek AS, Liu L, Naples M, Adeli K, Ng DS & Jin T 2009 Insulin stimulates the expression of carbohydrate response element binding protein (ChREBP) by attenuating the repressive effect of Pit-1, Oct-1/Oct-2, and Unc-86 homeodomain protein octamer transcription factor-1. Endocrinology 150 3483-3492. (doi:10.1210/en.2008-1702)
39. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S et al. 2007 A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 881-885. (doi:10.1038/ nature05616)
40. Sun J, Khalid S, Rozakis-Adcock M, Fantus IG & Jin T 2009 P-21-activated protein kinase-1 functions as a linker between insulin and Wnt signaling pathways in the intestine. Oncogene 28 3132-3144. (doi:10.1038/onc. 2009.167)
41. Sun J, Wang D & Jin T 2010 Insulin alters the expression of components of the Wnt signaling pathway including TCF-4 in the intestinal cells. Biochimica et Biophysica Acta 1800 344-351. (doi:10.1016/j.bbagen.2009.12.007)
42. Wang Q & Brubaker PL 2002 Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologia 45 1263-1273. (doi:10.1007/s00125-002-0828-3)
43. Wang P, Wang Q, Sun J, Wu J, Li H, Zhang N, Huang Y, Su B, Li RK, Liu L et al. 2009 POU homeodomain protein Oct-1 functions as a sensor for cyclic AMP. Journal of Biological Chemistry 284 26456-26465. (doi:10.1074/jbc.M109.030668)
44. Yi F, Brubaker PL & Jin T 2005 TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. Journal of Biological Chemistry 280 1457-1464. (doi:10.1074/jbc.M411487200)
45. Yi F, Sun J, Lim GE, Fantus IG, Brubaker PL & Jin T 2008 Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells. Endocrinology 149 2341-2351. (doi:10.1210/en.2007-1142) (Pubitemid 351574509)